Evaluation of Enzyme Inhibitors in Drug Discovery – A Guide for Medicinal Chemists and Pharmacologists, Second Edition
Autor RA Copelanden Limba Engleză Hardback – 15 apr 2013
Preț: 918.86 lei
Preț vechi: 967.22 lei
-5% Nou
Puncte Express: 1378
Preț estimativ în valută:
175.84€ • 184.95$ • 146.48£
175.84€ • 184.95$ • 146.48£
Carte tipărită la comandă
Livrare economică 03-17 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781118488133
ISBN-10: 111848813X
Pagini: 576
Dimensiuni: 163 x 245 x 38 mm
Greutate: 0.95 kg
Ediția:2nd Edition
Editura: Wiley
Locul publicării:Hoboken, United States
ISBN-10: 111848813X
Pagini: 576
Dimensiuni: 163 x 245 x 38 mm
Greutate: 0.95 kg
Ediția:2nd Edition
Editura: Wiley
Locul publicării:Hoboken, United States
Public țintă
Researchers and graduate students in biotechnology, Pharmaceutical sciences, medicinal chemists and biochemists, enzymologists, bioorganic chemists, and biophysicistsCuprins
Notă biografică
ROBERT A. COPELAND, PhD, is Executive Vice President and Chief Scientific Officer at Epizyme, Inc., a biopharmaceutical company in Cambridge, Massachusetts. He is on the Editorial Board of The Journal of Biological Chemistry and a member of the Faculty of 1000. Dr. Copeland has contributed more than 175 publications to the scientific literature and holds eight U.S.-issued patents. He has authored several books in protein science and enzymology, including Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis, Second Edition (Wiley).
Descriere
With enzymes being the most valued and common of drug targets, an understanding of their interactions with inhibitors is critical to successful drug discovery.